v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
REVENUE:        
Product revenue, net $ 3,290 $ 2,822 $ 7,717 $ 7,512
COSTS AND EXPENSES:        
Cost of revenue 1,367 1,555 5,582 6,582
Research and development 9,289 9,114 27,545 31,675
Selling, general and administrative 25,701 7,707 52,007 24,519
Asset impairment charges 58,957
  36,357 18,376 85,134 121,733
Operating loss (33,067) (15,554) (77,417) (114,221)
Grant income 982 1,668 2,941 1,668
Gain on change in fair value of warrant liabilities 6,150
Loss on extinguishment of debt 0 0 (2,092) 0
Interest income 1,231 18 2,802 21
Interest expense (301) (89) (954)
Other expense, net (1,156) (44) (3,256) (592)
Net loss available to common stockholders $ (32,010) $ (14,213) $ (77,111) $ (107,928)
Net loss per common share, diluted $ (3.59) $ (22.68) $ (10.42) $ (466.17)
Net loss per common share, basic $ (3.59) $ (22.68) $ (10.42) $ (466.17)
Weighted average common shares outstanding, basic 8,922,792 626,669 7,403,400 231,523
Weighted average common shares outstanding, diluted 8,922,792 626,669 7,403,400 231,523

Source